
Neosum Pharmaceuticals Private Limited
About Neosum Pharmaceuticals Private Limited
Data last updated:
Neosum Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 06 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC346951. Its GSTIN is 09AAGCN4396M1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhavna Kumari and Ravi Dutt.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at H.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094.
As per the financials filed for FY 2022, the company reported a revenue of ₹3.37 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net loss of ₹15,558 (net margin -4.6%) and EBITDA of -₹15,298 (EBITDA margin -4.5%). Revenue has grown at a compounded annual rate (CAGR) of 264% over three years.
Company details
Contact details
Neosum Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Neosum Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neosum Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neosum Pharmaceuticals Private Limited, buy the company report.
Financials of Neosum Pharmaceuticals Private Limited
FY 2022 filings availableNeosum Pharmaceuticals Private Limited reported revenue of ₹3.37 Lakh (up 25% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 264% over three years, including 25% growth in the latest year. EBITDA fell 260% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹3.37 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹15,298 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹15,558 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -4.5% | |||
| Net Profit Margin | -4.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Neosum Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neosum Pharmaceuticals Private Limited
Neosum Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavna Kumari | Director | 24 Jul 2023 | 3 Years 3 Months | Current |
| Ravi Dutt | Director | 06 Mar 2019 | 7 Years 8 Months | Current |
Peer comparison
Neosum Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ambiosis Pharmaceuticals Private Limited | ₹3.41 Lakh (FY 2025) | 5.0% | Bhopal, Madhya Pradesh, India | |||
| Sylum Pharmaceuticals Private Limited | ₹3.38 Lakh (FY 2022) | 85.0% | Solan, Himachal Pradesh, India | |||
| Neosum Pharmaceuticals Private Limitedthis company | ₹3.37 Lakh (FY 2022) | -₹15,558 | -4.6% | 25.0% | Delhi, India | |
| Nassid Pharmaceuticals Private Limited | ₹3.34 Lakh (FY 2017) | -2.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Neosum Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neosum Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neosum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neosum Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCN4396M1ZP | Uttar Pradesh | Active | 01 May 2019 |
To see the full GST registrations and return filing status of Neosum Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neosum Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Rohan Kumar ceased to be Director on 25 Jul 2023.
Frequently asked questions
Neosum Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 06 March 2019 (7+ years old) and is registered under CIN U51909DL2019PTC346951.
Neosum Pharmaceuticals has 2 current directors:
- Bhavna Kumari - Director
- Ravi Dutt - Director
The latest financial statements of Neosum Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Neosum Pharmaceuticals is 09AAGCN4396M1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Neosum Pharmaceuticals is U51909DL2019PTC346951. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neosum Pharmaceuticals was incorporated on 06 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Neosum Pharmaceuticals by revenue are Ambiosis Pharmaceuticals Private Limited, Sylum Pharmaceuticals Private Limited, Nassid Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rohan Kumar ceased to be Director on 25 Jul 2023. Bhavna Kumari was appointed as Director on 24 Jul 2023. Ravi Dutt was appointed as Director on 06 Mar 2019.
The registered office of Neosum Pharmaceuticals is at H.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094.
Neosum Pharmaceuticals operates in the trading industry, in the specialty segment.
Neosum Pharmaceuticals can be reached at its registered office: H.No. 9 Gali No.1 Ekta Gali Jogri Pur Gokal Pur, Delhi, India – 110094.

